UBS Group’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-914
Closed -$32.2K 10679
2026
Q1
$32.2K Buy
+914
New +$34.6K ﹤0.01% 7643
2025
Q3
Sell
-368
Closed -$12K 10548
2025
Q2
$12K Buy
+368
New +$10.5K ﹤0.01% 8759
2024
Q3
Sell
-28
Closed -$953 9722
2024
Q2
$953 Sell
28
-100,926
-100% -$3.12M ﹤0.01% 8724
2024
Q1
$3.12M Sell
100,954
-39
-0% -$1.12K ﹤0.01% 3478
2023
Q4
$2.69M Buy
100,993
+993
+1% +$24.3K ﹤0.01% 3494
2023
Q3
$2.38M Hold
100,000
﹤0.01% 3271
2023
Q2
$2.6M Buy
+100,000
New +$2.52M ﹤0.01% 3274

Other funds holding HCMT

UBS Group's HCMT Position: Q2 2026 in Review

UBS Group sold out of Direxion HCM Tactical Enhanced US ETF (HCMT) in Q2 2026, closing a stake of 914 shares — an estimated $32.2K sold.

UBS Group first reported a position in HCMT in Q2 2023 and held it in 7 quarters. The position peaked at $3.12M in Q1 2024. 41 funds tracked by Wall St. Rank hold HCMT as of Q2 2026.

  • UBS Group reported no remaining Direxion HCM Tactical Enhanced US ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 914 Direxion HCM Tactical Enhanced US ETF shares in Q2 2026, an estimated $32.2K.
  • UBS Group first reported a position in Direxion HCM Tactical Enhanced US ETF in Q2 2023 and held it in 7 quarters.
  • UBS Group's Direxion HCM Tactical Enhanced US ETF position peaked at $3.12M in Q1 2024.
  • 41 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.